Gynecologic Cancer Case Presentations (November 20, 2024)
This Gynecologic Oncology Tumor Board session will take place on Wednesday, November 20, 2024, at 7:00 a.m. This series is restricted to tumor board participants and will not be broadcast.
Activity Information
Needs Statement
Gynecologic oncologists, diagnostic radiologists, radiation oncologists, pathologists, clinical pharmacists, advanced practice providers, fellows, residents, and medical students need to receive regular updates on advances in gynecologic cancer research and clinical best practices. The series aims to advance the knowledge of learners, promote an interdisciplinary team approach to gynecologic oncology care, facilitate adherence to professional guidelines, increase molecular and genetic testing of patients, expand participation in clinical trials, and improve patient outcomes.
Educational Objectives
At the conclusion of the sessions, the participants should be able to:
- Facilitate effective collaboration and communication among an interprofessional care team in managing patients with gynecologic cancer.
- Adhere to professional standards, including the National Comprehensive Cancer Network practice guidelines, in treating patients with gynecologic cancer.
- Demonstrate the expanding role of molecular and genetic diagnostics in delivering precision treatments for gynecologic cancer.
- Appraise the clinical trials available to patients with gynecologic cancer and identify patients eligible for enrollment.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
- Obstetrics and Gynecology
- Oncology
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Director
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Activity Director
-
Tracilyn Rachelle Hall, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Savannah Barkdull, M.D., M.S.
Obstetrics and Gynecology Resident
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Caroline Davitt, M.D.
Obstetrics and Gynecology Resident
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Tiara Gatewood, M.A., M.B.A.
Academic Coordinator
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Tracilyn Rachelle Hall, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Ramya Masand, M.D.
Associate Professor of Gynecologic Oncology Pathology
Baylor College of Medicine
Disclosure:
Nothing to disclose.